Viaject
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
7922 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | 326 | 310 | 435 | 345 | 1497 | 2821 |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 170 | 207 | 422 | 440 | 1026 | 2214 |
| Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | 259 | 251 | 217 | 150 | 976 | 1784 |
| Insulin resistance | D007333 | EFO_0002614 | E88.819 | 139 | 209 | 117 | 200 | 1092 | 1710 |
| Obesity | D009765 | EFO_0001073 | E66.9 | 52 | 71 | 35 | 33 | 535 | 706 |
| Metabolic syndrome | D024821 | EFO_0000195 | E88.810 | 19 | 58 | 20 | 29 | 232 | 341 |
| Hypoglycemia | D007003 | — | E16.2 | 32 | 50 | 23 | 21 | 172 | 285 |
| Hyperglycemia | D006943 | — | R73.9 | 21 | 25 | 26 | 51 | 142 | 257 |
| Healthy volunteers/patients | — | — | — | 128 | 8 | 5 | 10 | 96 | 245 |
| Syndrome | D013577 | — | — | 13 | 35 | 15 | 15 | 147 | 214 |
Show 220 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 9 | 10 | 1 | — | 22 | 39 |
| Alzheimer disease | D000544 | EFO_0000249 | F03 | 4 | 17 | 1 | — | 15 | 34 |
| Neoplasms | D009369 | — | C80 | 9 | 6 | 1 | — | 16 | 31 |
| Diabetes complications | D048909 | — | — | 1 | 7 | 8 | — | 16 | 25 |
| Prostatic neoplasms | D011471 | — | C61 | 2 | 8 | 2 | — | 8 | 19 |
| Infections | D007239 | EFO_0000544 | — | — | 1 | 1 | — | 14 | 16 |
| Sepsis | D018805 | EFO_0001420 | A41.9 | 2 | 3 | 2 | — | 8 | 14 |
| Autoimmune diseases | D001327 | EFO_0000540 | M30-M36 | — | 3 | 2 | — | 9 | 14 |
| Cardiac surgical procedures | D006348 | — | — | — | 2 | 1 | — | 9 | 12 |
| Dementia | D003704 | EFO_0003862 | F03 | 2 | 8 | 1 | — | 3 | 12 |
Show 115 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Exercise | D015444 | EFO_0000483 | — | — | 1 | — | — | 23 | 24 |
| Spinal cord injuries | D013119 | EFO_1001919 | — | 3 | 3 | — | — | 10 | 15 |
| Hyperandrogenism | D017588 | — | — | 1 | 7 | — | — | 7 | 14 |
| Feeding behavior | D005247 | — | — | — | 1 | — | — | 11 | 12 |
| Pain | D010146 | EFO_0003843 | R52 | — | 1 | — | — | 9 | 10 |
| Endometrial neoplasms | D016889 | EFO_0004230 | — | 3 | 3 | — | — | 4 | 10 |
| Metabolism | D008660 | GO_0008152 | — | — | 2 | — | — | 7 | 9 |
| Parkinson disease | D010300 | EFO_0002508 | G20 | — | 6 | — | — | 3 | 9 |
| Nutritional and metabolic diseases | D009750 | — | — | — | 1 | — | — | 8 | 9 |
| Muscular atrophy | D009133 | — | — | 1 | 2 | — | — | 5 | 8 |
Show 166 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Sarcopenia | D055948 | EFO_1000653 | M62.84 | 2 | — | — | — | 16 | 18 |
| Gastric bypass | D015390 | EFO_0005244 | — | 3 | — | — | — | 6 | 9 |
| Pre-eclampsia | D011225 | EFO_0000668 | O14 | 1 | — | — | — | 7 | 8 |
| Carpal tunnel syndrome | D002349 | EFO_0004143 | G56.0 | 1 | — | — | — | 4 | 5 |
| Autonomic nervous system diseases | D001342 | EFO_0009532 | G90 | 2 | — | — | — | 3 | 5 |
| Hepatitis b | D006509 | — | — | 1 | — | — | — | 3 | 4 |
| Eczema | D004485 | — | L30.9 | 1 | — | — | — | 3 | 4 |
| Primary dysautonomias | D054969 | — | — | 3 | — | — | — | 1 | 4 |
| Pancreas transplantation | D016035 | — | — | 1 | — | — | — | 3 | 4 |
| Melanosis | D008548 | EFO_0003963 | L81.1 | 2 | — | — | — | 2 | 4 |
Show 56 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Blood glucose self-monitoring | D015190 | — | — | — | — | — | — | 15 | 15 |
| Communicable diseases | D003141 | — | — | — | — | — | — | 11 | 11 |
| Psoriasis | D011565 | EFO_0000676 | L40 | — | — | — | — | 10 | 10 |
| Feeding and eating disorders | D001068 | — | F50 | — | — | — | — | 10 | 10 |
| Pregnancy rate | D018873 | — | — | — | — | — | — | 10 | 10 |
| Body composition | D001823 | — | — | — | — | — | — | 10 | 10 |
| Healthy diet | D000072001 | — | — | — | — | — | — | 9 | 9 |
| Satiety response | D012528 | — | — | — | — | — | — | 8 | 8 |
| Surgical wound infection | D013530 | — | — | — | — | — | — | 8 | 8 |
| Lipid metabolism | D050356 | — | — | — | — | — | — | 7 | 7 |
Show 440 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | — |
| INN | — |
| Description | — |
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | — |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use